Talcum Powder Cancer Lawsuit

J & J's Secret Bankruptcy Plan Could Void $3.5 billion in Legal Settlements Plaintiffs Have Already Won In Court

One angle of the New Jersey-based company's bankruptcy plan was to effectively overturn a $2 billion jury award the US Supreme Court rejected hearing

Wednesday, February 9, 2022 - Once again, internal correspondence among executives from Johnson & Johnson shows that the health care giant may have conspired to deny women with ovarian cancer their day in court. Reuters reported that in 2021, the company formed a secret division of about 30 employees to draft a covert plan to potentially shelter tens of billions of dollars in awards being demanded by angry juries and save the company billions of dollars. Johnson & Johnson planned to create a subsidiary spin-off company to contain their talcum powder ovarian cancer and mesothelioma legal liabilities, fund the phony venture with a limited amount of cash ($2 billion), and then file for bankruptcy protection. The parent company would effectively shield the more than $400 billion in cash and assets previously exposed to talcum powder lawsuits. Women with cancer have proven in more than one dozen bellwether trials from California to New Jersey that Johnson's Baby Powder made from talc caused them to develop ovarian cancer, a death sentence for more than 95% of those who receive the diagnosis. The bankruptcy scheme called "The Texas Two-Step" would suspend all pending and current lawsuits indefinitely, and force plaintiffs dying from cancer to settle the more than 40,000 claims for pennies on the dollar. Reuters reports, "The goal, as a lawyer for the subsidiary said in a court filing: To halt all the litigation and transfer the cases to bankruptcy court, where plaintiffs would compete for compensation from a limited pool of money." Not only does the bankruptcy of LTL Management, J & J's talc liability shell company, shelter the parent company from future jury awards, it also suspends the payment of a $2 billion jury award in 2018, upheld by a Missouri Court of Appeals, and rejected by the US Supreme Court.

J & J spokespersons continue to claim that Johnson's Baby Powder, their iconic baby care product, is safe, pure, and asbestos-free. The company told Reuters that the bankruptcy plan has the best interests of the former customers that have filed suit in mind. The company refutes plaintiff allegations that if the bankruptcy plan goes forward, it would deny them their constitutionally-guaranteed day in court. "This filing follows established process, and courts have uniformly acknowledged that equitably resolving these types of claims through Chapter 11 is a legitimate use of the restructuring process," the statement said. "LTL's objective is to reach a fair and equitable resolution for claimants through a plan of reorganization and create a reasonable framework to address the unprecedented number of existing and future talc-related claims." Bankruptcy attorneys and scholars, and talcum powder cancer lawyers will have a chance to argue in the U.S. Bankruptcy Court in Trenton, N.J on February 15. The attorneys and professors think that allowing the Johnson & Johnson bankruptcy scheme to go forward would set a dangerous precedent for companies to avoid responsibility for negligence when their products harm consumers.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.